122 related articles for article (PubMed ID: 36599186)
1. A comparison of electrosprayed vs vortexed glycosaminoglycan-peptide nanoparticle platform for protection and improved delivery of therapeutic peptides.
Sodhi HS; Panitch A
Colloids Surf B Biointerfaces; 2023 Feb; 222():113112. PubMed ID: 36599186
[TBL] [Abstract][Full Text] [Related]
2. A Tunable Glycosaminoglycan-Peptide Nanoparticle Platform for the Protection of Therapeutic Peptides.
Sodhi H; Panitch A
Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399234
[TBL] [Abstract][Full Text] [Related]
3. Excipients for the lyoprotection of MAPKAP kinase 2 inhibitory peptide nano-polyplexes.
Mukalel AJ; Evans BC; Kilchrist KV; Dailing EA; Burdette B; Cheung-Flynn J; Brophy CM; Duvall CL
J Control Release; 2018 Jul; 282():110-119. PubMed ID: 29709529
[TBL] [Abstract][Full Text] [Related]
4. Korean red ginseng water extract alleviates atopic dermatitis-like inflammatory responses by negative regulation of mitogen-activated protein kinase signaling pathway in vivo.
Park JH; Ahn EK; Ko HJ; Lee JY; Hwang SM; Ko S; Oh JS
Biomed Pharmacother; 2019 Sep; 117():109066. PubMed ID: 31226639
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effect of collagen tripeptide in atopic dermatitis.
Hakuta A; Yamaguchi Y; Okawa T; Yamamoto S; Sakai Y; Aihara M
J Dermatol Sci; 2017 Dec; 88(3):357-364. PubMed ID: 29017796
[TBL] [Abstract][Full Text] [Related]
6. Keratinocytes: innate immune cells in atopic dermatitis.
Chieosilapatham P; Kiatsurayanon C; Umehara Y; Trujillo-Paez JV; Peng G; Yue H; Nguyen LTH; Niyonsaba F
Clin Exp Immunol; 2021 Jun; 204(3):296-309. PubMed ID: 33460469
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatase conjugated with a novel transdermal delivery peptide, astrotactin 1-derived peptide recombinant protein tyrosine phosphatase (AP-rPTP), alleviates both atopic dermatitis-like and psoriasis-like dermatitis.
Kim WJ; Koo JH; Cho HJ; Lee JU; Kim JY; Lee HG; Lee S; Kim JH; Oh MS; Suh M; Shin EC; Ko JY; Sohn MH; Choi JM
J Allergy Clin Immunol; 2018 Jan; 141(1):137-151. PubMed ID: 28456618
[TBL] [Abstract][Full Text] [Related]
8. D-Mannose ameliorates DNCB-induced atopic dermatitis in mice and TNF-α-induced inflammation in human keratinocytes via mTOR/NF-κB pathway.
Luo J; Li Y; Zhai Y; Liu Y; Zeng J; Wang D; Li L; Zhu Z; Chang B; Deng F; Zhang J; Zhou J; Sun L
Int Immunopharmacol; 2022 Dec; 113(Pt A):109378. PubMed ID: 36327873
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers.
Liu Y; Shipton MK; Ryan J; Kaufman ED; Franzen S; Feldheim DL
Anal Chem; 2007 Mar; 79(6):2221-9. PubMed ID: 17288407
[TBL] [Abstract][Full Text] [Related]
10. Igalan from Inula helenium (L.) suppresses the atopic dermatitis-like response in stimulated HaCaT keratinocytes via JAK/STAT3 signaling.
Dao TTP; Song K; Kim JY; Kim YS
Inflamm Res; 2020 Mar; 69(3):309-319. PubMed ID: 32002586
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effects of antimycotics on thymic stromal lymphopoietin production in human keratinocytes.
Hau CS; Kanda N; Watanabe S
J Dermatol Sci; 2013 Sep; 71(3):174-83. PubMed ID: 23688403
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of chamomile oil and nanoemulgels as a promising treatment option for atopic dermatitis induced in rats.
El-Salamouni NS; Ali MM; Abdelhady SA; Kandil LS; Elbatouti GA; Farid RM
Expert Opin Drug Deliv; 2020 Jan; 17(1):111-122. PubMed ID: 31782320
[No Abstract] [Full Text] [Related]
13. Terminalia chebula Retz. extract ameliorates the symptoms of atopic dermatitis by regulating anti-inflammatory factors in vivo and suppressing STAT1/3 and NF-ĸB signaling in vitro.
Kim HJ; Song HK; Park SH; Jang S; Park KS; Song KH; Lee SK; Kim T
Phytomedicine; 2022 Sep; 104():154318. PubMed ID: 35830757
[TBL] [Abstract][Full Text] [Related]
14. A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents.
Tanimoto A; Shinozaki Y; Yamamoto Y; Katsuda Y; Taniai-Riya E; Toyoda K; Kakimoto K; Kimoto Y; Amano W; Konishi N; Hayashi M
Exp Dermatol; 2018 Jan; 27(1):22-29. PubMed ID: 28423239
[TBL] [Abstract][Full Text] [Related]
15. Topical treatment with mastic (resin from Pistacia lentiscus) elicits anti-inflammatory and anti-pruritic responses by modulating keratinocyte activation in a mouse model of allergic dermatitis.
Kishimoto R; Kato N; Koike M; Iwashita N; Takagi Y; Fukuyama T
Phytomedicine; 2021 Oct; 91():153679. PubMed ID: 34332283
[TBL] [Abstract][Full Text] [Related]
16. Emerging topical drug delivery approaches for the treatment of Atopic dermatitis.
Ghosalkar S; Singh P; Ravikumar P
J Cosmet Dermatol; 2022 Feb; 21(2):536-549. PubMed ID: 34935274
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisone-loaded chitosan nanoparticles.
Hussain Z; Katas H; Mohd Amin MC; Kumolosasi E; Sahudin S
Int J Nanomedicine; 2014; 9():5143-56. PubMed ID: 25395851
[TBL] [Abstract][Full Text] [Related]
18. Chemistry of aqueous silica nanoparticle surfaces and the mechanism of selective peptide adsorption.
Patwardhan SV; Emami FS; Berry RJ; Jones SE; Naik RR; Deschaume O; Heinz H; Perry CC
J Am Chem Soc; 2012 Apr; 134(14):6244-56. PubMed ID: 22435500
[TBL] [Abstract][Full Text] [Related]
19. Experimental atopic dermatitis is dependent on the TWEAK/Fn14 signaling pathway.
Liu Q; Wang H; Wang X; Lu M; Tan X; Peng L; Tan F; Xiao T; Xiao S; Xia Y
Clin Exp Immunol; 2020 Jan; 199(1):56-67. PubMed ID: 31515807
[TBL] [Abstract][Full Text] [Related]
20. Understanding the Interplay between Self-Assembling Peptides and Solution Ions for Tunable Protein Nanoparticle Formation.
Shanbhag BK; Liu C; Haritos VS; He L
ACS Nano; 2018 Jul; 12(7):6956-6967. PubMed ID: 29928801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
